T. Rowe Price Associates’s Ocugen OCGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-123,718
| Closed | -$88K | – | 3122 |
|
|
2025
Q1 | $88K | Buy |
123,718
+10,646
| +9% | +$7.57K | ﹤0.01% | 2846 |
|
|
2024
Q4 | $91K | Sell |
113,072
-122,788
| -52% | -$98.8K | ﹤0.01% | 2837 |
|
|
2024
Q3 | $235K | Sell |
235,860
-32,960
| -12% | -$32.8K | ﹤0.01% | 2589 |
|
|
2024
Q2 | $417K | Buy |
268,820
+81,720
| +44% | +$127K | ﹤0.01% | 2264 |
|
|
2024
Q1 | $307K | Hold |
187,100
| – | – | ﹤0.01% | 2421 |
|
|
2023
Q4 | $108K | Buy |
187,100
+93,000
| +99% | +$53.7K | ﹤0.01% | 2706 |
|
|
2023
Q3 | $38K | Buy |
94,100
+62,800
| +201% | +$25.4K | ﹤0.01% | 2800 |
|
|
2023
Q2 | $17K | Sell |
31,300
-137,003
| -81% | -$74.4K | ﹤0.01% | 2863 |
|
|
2023
Q1 | $144K | Buy |
168,303
+4,571
| +3% | +$3.91K | ﹤0.01% | 2608 |
|
|
2022
Q4 | $213K | Buy |
163,732
+26,910
| +20% | +$35K | ﹤0.01% | 2502 |
|
|
2022
Q3 | $244K | Buy |
136,822
+12,800
| +10% | +$22.8K | ﹤0.01% | 2467 |
|
|
2022
Q2 | $282K | Sell |
124,022
-6,220
| -5% | -$14.1K | ﹤0.01% | 2465 |
|
|
2022
Q1 | $430K | Buy |
130,242
+2,609
| +2% | +$8.61K | ﹤0.01% | 2398 |
|
|
2021
Q4 | $581K | Buy |
127,633
+21,576
| +20% | +$98.2K | ﹤0.01% | 2313 |
|
|
2021
Q3 | $761K | Buy |
106,057
+65,800
| +163% | +$472K | ﹤0.01% | 2177 |
|
|
2021
Q2 | $323K | Buy |
40,257
+27,957
| +227% | +$224K | ﹤0.01% | 2564 |
|
|
2021
Q1 | $84K | Buy |
+12,300
| New | +$84K | ﹤0.01% | 2787 |
|